Sagility India Ltd IPO

The healthcare services industry is highly competitive and if the company is unable to compete effectively, it may adversely affect its business, financial condition and results of operations.

The company's business is solely focused on the U.S. healthcare industry and may be adversely affected by factors affecting the U.S. healthcare industry, including a decline in the growth of the U.S. healthcare industry, reduction in outsourcing and other trends.

The company has, in the 12 months preceding the date of this Red Herring Prospectus, issued Equity Shares at a price which may be significantly lower than the Offer Price.

Goodwill and other intangible assets are its largest assets. Any impairment to the company goodwill or other intangible assets may adversely affect its reputation and financial condition.

One of its Independent Directors has received summons in relation to an ongoing investigation by SEBI of Linde India Limited and the matter is currently pending.

Pursuant to an external financing facility availed by one of its Promoters, Sagility B.V., shares of Sagility B.V. held by the company other Promoter, Sagility Holdings B.V. are pledged. In case of an event of default and consequent invocation of security, there may be a change in control, which may adversely impact its business. Further, the terms of such facility also impose certain conditions on disposal of assets of Sagility B.V., including Equity Shares of the Company, which may impact the Offer.

Anti-outsourcing legislation could adversely affect its business, financial condition and results of operations and impair the company ability to service its customers.

A downgrade in its credit rating could adversely affect the company ability to raise capital in the future.

Any failures to protect its proprietary technologies or information or the company intellectual property rights may have an adverse effect on its business, financial condition, and results of operations.

Its ability to invest in foreign subsidiaries or joint ventures is constrained by applicable restrictions under Indian overseas investment laws as well as laws of the relevant international jurisdictions, which could adversely affect its business prospects and international growth strategy.